Subscribe To
Baudax Bio Announces Closing of $5 Million Public Offering
MALVERN, Pa., Dec. 06, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (the “Company” or “Baudax Bio”) (NASDAQ: BXRX), a pharmaceutical company focused on innovative products for hospital and related settings, today announced the closing of its previously announced public offering of an aggregate of 1,042,787 shares of its common stock (or pre-funded warrants in lieu […] The post Baudax Bio Announces Closing of $5 Million Public Offering appeared first on ForexTV...
Read More
Posted: Dec 6 2022, 21:11
Author Name: forextv
Views: 111568